Recent Finacing
Recent Raise
OncoTartis is a Buffalo-based biotechnology company developing tissue-targeted NAMPT inhibitor therapies for hematological malignancies; lead candidate OT-82 shows selective toxicity and preclinical efficacy in leukemia and lymphoma models.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
